{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:23:29Z","timestamp":1784748209332,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"USA National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA187027"],"award-info":[{"award-number":["R01 CA187027"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.livres.2020.11.002","type":"journal-article","created":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T22:03:38Z","timestamp":1604873018000},"page":"212-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Yes-associated protein-1 may serve as a diagnostic marker and therapeutic target for residual\/recurrent hepatocellular carcinoma post-transarterial chemoembolization"],"prefix":"10.1016","volume":"4","author":[{"family":"Xia Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahee","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex S.","family":"Befeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningling","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2020.11.002_bib1","first-page":"7","article-title":"Cancer statistics","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.livres.2020.11.002_bib2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2020.11.002_bib3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","article-title":"Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma","volume":"150","author":"Bruix","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2020.11.002_bib4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2020.11.002_bib5","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1053\/j.gastro.2004.09.032","article-title":"Chemoembolization for hepatocellular carcinoma","volume":"127","author":"Bruix","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2020.11.002_bib6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ejrad.2008.08.007","article-title":"Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications","volume":"72","author":"Vogl","year":"2009","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.livres.2020.11.002_bib7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1186\/1471-2407-12-584","article-title":"Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation","volume":"12","author":"Zeng","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.livres.2020.11.002_bib8","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/lt.22314","article-title":"Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation","volume":"17","author":"Zen","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.livres.2020.11.002_bib9","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3390\/cancers12030684","article-title":"The cancer stem cell in hepatocellular carcinoma","volume":"12","author":"Schulte","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.livres.2020.11.002_bib10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/his.12623","article-title":"Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinoma","volume":"67","author":"Lai","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.livres.2020.11.002_bib11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41568-019-0168-y","article-title":"YAP and TAZ: a signalling hub of the tumour microenvironment","volume":"19","author":"Zanconato","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.livres.2020.11.002_bib12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1517\/14728222.2010.499361","article-title":"Targeting YAP and Hippo signaling pathway in liver cancer","volume":"14","author":"Liu","year":"2010","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.livres.2020.11.002_bib13","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/ijc.31561","article-title":"A\u00a0time for YAP1: tumorigenesis, immunosuppression and targeted therapy","volume":"143","author":"Shibata","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.livres.2020.11.002_bib14","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.humpath.2008.04.012","article-title":"Expression of Yes-associated protein in common solid tumors","volume":"39","author":"Steinhardt","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.livres.2020.11.002_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cell.2005.06.007","article-title":"The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP","volume":"122","author":"Huang","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.livres.2020.11.002_bib16","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/dvdy.21996","article-title":"Regulation of organ size: insights from the Drosophila Hippo signaling pathway","volume":"238","author":"Kango-Singh","year":"2009","journal-title":"Dev Dyn"},{"key":"10.1016\/j.livres.2020.11.002_bib17","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1101\/gad.1903310","article-title":"The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation","volume":"24","author":"Lian","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.livres.2020.11.002_bib18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jhep.2018.05.008","article-title":"Liver regeneration requires Yap1-TGFbeta-dependent epithelial-mesenchymal transition in hepatocytes","volume":"69","author":"Oh","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2020.11.002_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.stem.2019.04.005","article-title":"YAP, but not RSPO-LGR4\/5, signaling in biliary epithelial cells promotes a ductular reaction in response to liver injury","volume":"25","author":"Planas-Paz","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.livres.2020.11.002_bib20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1053\/j.gastro.2016.10.047","article-title":"Hippo signaling in the liver regulates organ size, cell fate, and carcinogenesis","volume":"152","author":"Patel","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2020.11.002_bib21","article-title":"Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma","volume":"8","author":"Kim","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.livres.2020.11.002_bib22","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cell.2014.03.060","article-title":"Hippo pathway activity influences liver cell fate","volume":"157","author":"Yimlamai","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.livres.2020.11.002_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbadis.2007.12.004","article-title":"Stem cells, cell transplantation and liver repopulation","volume":"1782","author":"Oertel","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.livres.2020.11.002_bib24","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/hep.24157","article-title":"Human hepatic stem cell and maturational liver lineage biology","volume":"53","author":"Turner","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2020.11.002_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fcell.2019.00033","article-title":"Hippo signaling in the liver - a long and ever-expanding story","volume":"7","author":"Manmadhan","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.livres.2020.11.002_bib26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/mpo.10175","article-title":"Stem-like cells in hepatoblastoma","volume":"39","author":"Ruck","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.livres.2020.11.002_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ebiom.2018.08.010","article-title":"miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression","volume":"35","author":"Chen","year":"2018","journal-title":"EBioMedicine"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568420300581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568420300581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:44:02Z","timestamp":1762872242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568420300581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2542568420300581"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2020.11.002","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yes-associated protein-1 may serve as a diagnostic marker and therapeutic target for residual\/recurrent hepatocellular carcinoma post-transarterial chemoembolization","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2020.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Third Affiliated Hospital of Sun Yat-sen University. Publishing Services by Elsevier B. V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}